The FDA approved Yuvezzi, a fixed-dose combination eye drop of carbachol and brimonidine tartrate, for the treatment of presbyopia in adult patients.

Glymphatic dysfunction in IIH appears to be an adaptive response to elevated pressure rather than a primary cause of the ...

The Vision Health Initiative faces a $2 million budget cut in the FY26 appropriations bill, potentially limiting US ocular ...

Patients’ financial resources affect their enrollment in oncology clinical trials to a greater degree than traditional demographic characteristics.

Perioperative prostaglandin analog use is not associated with increased risk for pseudophakic cystoid macular edema after cataract surgery.

Corneal shape does not appear to be affected significantly by either high- or low-concentration atropine in children.

Federal officials have lifted a short pause on more than 100 public health grants worth over $5 billion, allowing states to continue work aimed at strengthening health systems.

The United States has officially pulled out of the World Health Organization (WHO), a year after President Donald Trump announced plans to leave the global health group.

Effective prevention and management of type 2 diabetes mellitus (T2DM) can improve patient outcomes and reduce health care-related environmental impact.

HealthDay News — At 11 to 18 months after acute mpox, post-mpox sequelae persist frequently, according to a study published online Jan. 20 in the Annals of Internal Medicine.